热门资讯> 正文

LIXTE Biotechnology重新获得纳斯达克合规

2025-07-16 20:34

LIXTE Biotechnology (NASDAQ:LIXT) announced on Wednesday it has received a Nasdaq letter, stating that the company has regained compliance with Nasdaq’s Listing Rule, requiring a minimum equity requirement of $2.5 million for continued listing.
Shares of LIXT slipped over 17% to $3.0649 during premarket trading.
Source: Press Release

More on Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology announces $5M equity financing; shares down
Financial information for Lixte Biotechnology Holdings, Inc.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。